Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sickle - Beta Thalassemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02179359
What this trial is testing

Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseTransfusion Dependent Alpha- or Beta- ThalassemiaDiamond Blackfan Anemia+5 more
Masonic Cancer Center, University of Minnesota 38
Testing effectiveness (Phase 2)Study completedNCT01186419
What this trial is testing

Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-thalassemia
Shire 51
Early research (Phase 1)Active Not RecruitingNCT03282656
What this trial is testing

Gene Transfer for Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
David Williams 10
Large-scale testing (Phase 3)Enrolling By InvitationNCT04208529
What this trial is testing

A Long-term Follow-up Study in Participants Who Received CTX001

Who this might be right for
Beta-ThalassemiaThalassemiaSickle Cell Disease+4 more
Vertex Pharmaceuticals Incorporated 160
Testing effectiveness (Phase 2)Study completedNCT00153985
What this trial is testing

Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies

Who this might be right for
HemoglobinopathiesSickle Cell DiseaseThalassemia
Dana-Farber Cancer Institute 2
Not applicableStudy completedNCT06831799
What this trial is testing

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Who this might be right for
HemoglobinopathiesSickle Cell DiseaseSickle Cell Anemia+21 more
Hospital Universitari Vall d'Hebron Research Institute 684
Testing effectiveness (Phase 2)WithdrawnNCT01419704
What this trial is testing

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Who this might be right for
Anemia, Sickle CellComplex and Transfusion-dependent HemoglobinopathiesThalassemia+4 more
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Ended earlyNCT01363908
What this trial is testing

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-Thalassemia
Shire 30
Testing effectiveness (Phase 2)Study completedNCT01049854
What this trial is testing

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

Who this might be right for
LeukemiaLymphomaBone Marrow Failure+5 more
New York Medical College 20
Not applicableUnknownNCT01092169
What this trial is testing

Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-Thalassemia

Who this might be right for
Sickle Cell AnemiaBeta-ThalassemiaMicroalbuminuria
Hillel Yaffe Medical Center
Not applicableStudy completedNCT01241357
What this trial is testing

High-Tc Susceptometer to Monitor Transfusional Iron Overload

Who this might be right for
Transfusional Iron OverloadThalassemia MajorSickle Cell Disease+2 more
Columbia University 99
Not applicableNot Yet RecruitingNCT05883254
What this trial is testing

Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia

Who this might be right for
Sickle Cell Disease, Beta Thalassemia Intermedia
Assiut University 80
Large-scale testing (Phase 3)UnknownNCT04191213
What this trial is testing

Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients

Who this might be right for
Sickle Cell Anemia in Children
Al-Neelain University 100
Testing effectiveness (Phase 2)Study completedNCT03763656
What this trial is testing

Pharmacokinetics of Oral Hydroxyurea Solution

Who this might be right for
Sickle Cell DiseaseSickle-Cell; Hemoglobin Disease, ThalassemiaSickle Cell-beta-thalassemia+1 more
Nova Laboratories Limited 33
Not applicableStudy completedNCT00342043
What this trial is testing

Examination of Protective Factors Against Severe Malaria

Who this might be right for
MalariaSevere Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 4,850
Post-approval studies (Phase 4)Study completedNCT00749515
What this trial is testing

Pilot Study for Patients With Poor Response to Deferasirox

Who this might be right for
Transfusion-dependent HemachromatosisThalassemia MajorSickle Cell Disease
Boston Children's Hospital 15
Not applicableStudy completedNCT00972231
What this trial is testing

Iron Overload and Growth Velocity in Thalassemia and Sickle Cell Anemia

Who this might be right for
ThalassemiaSickle Cell Disease
HaEmek Medical Center, Israel 93
Not applicableStudy completedNCT05506358
What this trial is testing

Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada

Who this might be right for
Sickle Cell DiseaseSickle Cell TraitBeta-Thalassemia+2 more
University of British Columbia 145
Not applicableLooking for participantsNCT04416178
What this trial is testing

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

Who this might be right for
Sickle Cell Disease
St. Jude Children's Research Hospital 352
Testing effectiveness (Phase 2)Looking for participantsNCT05736419
What this trial is testing

Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Sickle Cell DiseaseThalassemia, BetaThalassemia
Memorial Sloan Kettering Cancer Center 24
Next Page